Synergistic Action of AMX Associated with 1,8-Cineole and Its Effect on the ESBL Enzymatic Resistance Mechanism
- PMID: 35892393
- PMCID: PMC9331605
- DOI: 10.3390/antibiotics11081002
Synergistic Action of AMX Associated with 1,8-Cineole and Its Effect on the ESBL Enzymatic Resistance Mechanism
Abstract
The purpose of the present study is twofold. First, it aims to evaluate the synergistic action of the ß-lactam antibiotic; AMX is associated with 1,8-cineole on six clinical isolates of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains. Second, it aims to determine the effect this association has on the ESBL enzymatic resistance mechanism. The synergistic action of AMX/1,8-cineole was evaluated using partial inhibitory concentrations (PIC), determined by a microplate, a checkerboard and time-kill assays. The effect of AMX/1,8-cineole associations on the ESBL enzymatic resistance mechanism was evaluated using a new optimized enzymatic assay. This assay was based on the determination of the AMX antibacterial activity when combined with 1,8-cineole (at subinhibitory concentrations) in the presence or absence of the ß-lactamase enzyme toward a sensitive E. coli strain. The results of both checkerboard and time-kill assays showed a strong synergistic action between AMX and 1,8-cineole. The results of the enzymatic assay showed that the combination of AMX with 1,8-cineole notably influences the enzymatic resistance of the reaction by decreasing the affinity of the β-lactam antibiotic, AMX, to the β-lactamase enzyme. All obtained results suggested that the AMX/1,8-cineole association could be employed in therapy to overcome bacterial resistance to AMX while reducing the prevalence of resistance.
Keywords: 1,8-cineole; Escherichia coli; Klebsiella pneumomniae; amoxicillin; extended-spectrum beta-lactamases (ESBL); resistance; synergistic action.
Conflict of interest statement
The authors declare that there are no conflict of interest related to this research paper.
Figures
References
-
- WHO Antimicrobial Resistance: Global Report on Surveillance. 2014. [(accessed on 1 April 2022)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/112647/WHO_HSE_PED_AIP_....
-
- Gautret P., Lagier J.C., Parola P., Meddeb L., Sevestre J., Mailhe M., Doudier B., Aubry C., Amrane S., Seng P., et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med. Infect. Dis. 2020;34:101663. doi: 10.1016/j.tmaid.2020.101663. - DOI - PMC - PubMed
-
- Lanckohr C. Rational use of antibiotics in the era of multi-resistance. Anästh. Intensivmed. 2022;63:26–33. doi: 10.19224/ai2022.02. - DOI
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
